Assignee
MINDSET PHARMA INC
CA·8 granted patents·15 pending applications·18 citations·filing 2021–2025
Top patents by PatentIndex Score
23 records- 0197US11591353B2Psilocin derivatives as serotonergic psychedelic agents for the treatment of CNS disordersMINDSET PHARMA INC·Filed 2022·Granted Feb 28, 2023·9 cites·15 claims
- 0296US11597738B2Psilocin derivatives as serotonergic psychedelic agents for the treatment of CNS disordersMINDSET PHARMA INC·Filed 2022·Granted Mar 7, 2023·4 cites·29 claims
- 0396US11427604B2Psilocin derivatives as serotonergic psychedelic agents for the treatment of CNS disordersMINDSET PHARMA INC·Filed 2021·Granted Aug 30, 2022·4 cites·30 claims
- 0489US12378266B2Psilocin derivatives as serotonergic psychedelic agents for the treatment of CNS disordersMINDSET PHARMA INC·Filed 2024·Granted Aug 5, 2025·0 cites·45 claims
- 0589US12054504B23-pyrrolidine-indole derivatives as serotonergic psychedelic agents for the treatment of CNS disordersMINDSET PHARMA INC·Filed 2022·Granted Aug 6, 2024·1 cites·17 claims
- 0688US2025388611A1Psilocin derivatives as serotonergic psychedelic agents for the treatment of cns disordersMINDSET PHARMA INC·Filed 2024·Application pending·0 cites
- 0782US12054505B2Psilocin derivatives as serotonergic psychedelic agents for the treatment of CNS disordersMINDSET PHARMA INC·Filed 2022·Granted Aug 6, 2024·0 cites·21 claims
- 0882US2023167141A1Psilocin derivatives as serotonergic psychedelic agents for the treatment of cns disordersMINDSET PHARMA INC·Filed 2023·Application pending·0 cites
- 0980US2023203070A1Psilocin derivatives as serotonergic psychedelic agents for the treatment of cns disordersMINDSET PHARMA INC·Filed 2023·Application pending·0 cites
- 1080US2026092035A1Indole derivatives as serotonergic agents useful for the treatment of disorders related theretoMINDSET PHARMA INC·Filed 2025·Application pending·0 cites
- 1177US2024336641A13-pyrrolidine-indole derivatives as serotonergic psychedelic agents for the treatment of cns disordersMINDSET PHARMA INC·Filed 2024·Application pending·0 cites
- 1273US2025034106A13-cycloamino-indole compounds as serotonergic agents useful for the treatment of disorders related theretoMINDSET PHARMA INC·Filed 2022·Application pending·0 cites
- 1372US11453689B23-pyrrolidine-indole derivatives as serotonergic psychedelic agents for the treatment of CNS disordersMINDSET PHARMA INC·Filed 2021·Granted Sep 27, 2022·0 cites·28 claims
- 1471US2025353827A1Indoline derivatives as serotonergic agents useful for the treatment of disorders related theretoMINDSET PHARMA INC·Filed 2023·Application pending·0 cites
- 1571US2026083703A1Indoline derivatives as serotonergic agents useful for the treatment of disorders related theretoMINDSET PHARMA INC·Filed 2023·Application pending·0 cites
- 1670US2024376052A1N-substituted indole derivatives as serotonergic agents useful for the treatment of disorders related theretoMINDSET PHARMA INC·Filed 2022·Application pending·0 cites
- 1770US2024383850A1Indole derivatives as serotonergic agents useful for the treatment of disorders related theretoMINDSET PHARMA INC·Filed 2022·Application pending·0 cites
- 1867US2025257034A1Indole derivatives as serotonergic agents useful for the treatment of disorders related theretoMINDSET PHARMA INC·Filed 2025·Application pending·0 cites
- 1962US2024166599A1Indole derivatives as serotonergic agents useful for the treatment of disorders related theretoMINDSET PHARMA INC·Filed 2022·Application pending·0 cites
- 2062US2024166630A1Indole derivatives as serotonergic agents useful for the treatment of disorders related theretoMINDSET PHARMA INC·Filed 2022·Application pending·0 cites
- 2161US12590060B2Scalable synthetic route for psilocin and psilocybinMINDSET PHARMA INC·Filed 2021·Granted Mar 31, 2026·0 cites·24 claims
- 2256US2024342126A1Hallucinogen-fatty acid combinationMINDSET PHARMA INC·Filed 2022·Application pending·0 cites
- 2354US2024051978A13-cyclic amine-indole derivatives as serotonergic agents for the treatment of cns disordersMINDSET PHARMA INC·Filed 2021·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →